Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline with or without individual counselling for smoking cessation in Dutch primary care
NL-OMON36281Phase 4Not yet recruiting
- Sponsor
- Maastricht University
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Maastricht University. Primary endpoint: Prolonged abstinence from smoking from week 9 through week 26. Planned start Sep 2011; status: not yet recruiting.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NL-OMON36281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36281.